share_log

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Needham重申買入Phathom Pharmicals,維持26美元的目標股價
Moomoo 24/7 ·  03/22 14:14

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

尼德姆分析師約瑟夫·斯金格重申Phathom Pharmicals(納斯達克股票代碼:PHAT)的買入並維持26美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論